The DOI matches its Crossref record; 289 of the 289 references it cites were found in a registry or an index.
Somatostatin receptors: From signaling to clinical practice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Seger, R., & Krebs, E. G. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.9.7601337 · Cited by 3,602
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Shaw, R. J., & Cantley, L. C. (2006) · Nature · doi:10.1038/nature04869 · Cited by 2,019
Somatostatin and Its Receptor Family
Patel, Y. C. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1999.0183 · Cited by 1,648
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Kwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
The Pezcoller lecture: cancer cell cycles revisited.
Sherr, C. J. (2000) · PubMed · Cited by 1,409
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
Bauer, W., Briner, U., Doepfner, W., Haller, R., Huguenin, R., Marbach, P., Petcher, T. J., & Pless, J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90087-x · Cited by 1,331
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals
Luttrell, L. M., & Lefkowitz, R. J. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.455 · Cited by 1,122
Pavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., & Roberts, J. M. (1992) · Science · doi:10.1126/science.1388288 · Cited by 1,043
Lamberts, S. W. J., van der Lely, A.-J., de Herder, W. W., & Hofland, L. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601253340408 · Cited by 1,001
Rocheville, M., Lange, D. C., Kumar, U., Patel, S. C., Patel, R. C., & Patel, Y. C. (2000) · Science · doi:10.1126/science.288.5463.154 · Cited by 888
Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression
Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Trainer, P. J., Drake, W. M., Katznelson, L., Freda, P. U., Herman-Bonert, V., van der Lely, A. J., Dimaraki, E. V., Stewart, P. M., Friend, K. E., Vance, M. L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004203421604 · Cited by 879
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
Advances in the Treatment of Prolactinomas
Gillam, M. P., Molitch, M. E., Lombardi, G., & Colao, A. (2006) · Endocrine Reviews · doi:10.1210/er.2005-9998 · Cited by 824
The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
LAMBERTS, S. W. J., KRENNING, E. P., & REUBI, J.-C. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-4-450 · Cited by 805
Guidelines for Acromegaly Management: An Update
Melmed, S., Colao, A., Barkan, A., Molitch, M., Grossman, A. B., Kleinberg, D., Clemmons, D., Chanson, P., Laws, E., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 764
Yamada, Y., Post, S. R., Wang, K., Tager, H. S., Bell, G. I., & Seino, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.251 · Cited by 753
Bruns, C., Lewis, I., Briner, U., Meno-Tetang, G., & Weckbecker, G. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460707 · Cited by 692
Reubi, J., Waser, B., Schaer, J.-C., & Laissue, J. A. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100541 · Cited by 657
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Yao, J. C., Phan, A. T., Chang, D. Z., Wolff, R. A., Hess, K., Gupta, S., Jacobs, C., Mares, J. E., Landgraf, A. N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.7858 · Cited by 649
Yao, J. C., Lombard-Bohas, C., Baudin, E., Kvols, L. K., Rougier, P., Ruszniewski, P., Hoosen, S., St. Peter, J., Haas, T., Lebwohl, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2669 · Cited by 647
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
van der Lely, A. J., Hutson, R. K., Trainer, P. J., Besser, G. M., Barkan, A. L., Katznelson, L., Klibanski, A., Herman-Bonert, V., Melmed, S., Vance, M. L., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06844-1 · Cited by 645
Imhof, A., Brunner, P., Marincek, N., Briel, M., Schindler, C., Rasch, H., Mäcke, H. R., Rochlitz, C., Müller-Brand, J., & Walter, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7873 · Cited by 641
A 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN
Krenning, E. P., Breeman, W. A. P., Kooij, P. P. M., Lameris, J. S., Bakker, W. H., Koper, J. W., Ausema, L., Reubi, J. C., & Lamberts, S. W. J. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91258-0 · Cited by 625
Pituitary Adenoma Predisposition Caused by Germline Mutations in the AIP Gene
Vierimaa, O., Georgitsi, M., Lehtonen, R., Vahteristo, P., Kokko, A., Raitila, A., Tuppurainen, K., Ebeling, T. M. L., Salmela, P. I., Paschke, R., et al. (2006) · Science · doi:10.1126/science.1126100 · Cited by 618
Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents
Kleuss, C., Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G., & Wittig, B. (1991) · Nature · doi:10.1038/353043a0 · Cited by 579
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers
Rocheville, M., Lange, D. C., Kumar, U., Sasi, R., Patel, R. C., & Patel, Y. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7862 · Cited by 527
Yu, J., Zhang, Y., McIlroy, J., Rordorf-Nikolic, T., Orr, G. A., & Backer, J. M. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1379 · Cited by 520
Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas
Koerker, D. J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C. J., Ensinck, J., & Gale, C. C. (1974) · Science · doi:10.1126/science.184.4135.482 · Cited by 519
Ginj, M., Zhang, H., Waser, B., Cescato, R., Wild, D., Wang, X., Erchegyi, J., Rivier, J., Mäcke, H. R., & Reubi, J. C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607761103 · Cited by 515
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
The Pathophysiological Consequences of Somatostatin Receptor Internalization and Resistance
Hofland, L. J., & Lamberts, S. W. J. (2003) · Endocrine Reviews · doi:10.1210/er.2000-0001 · Cited by 474
Dopamine Agonists and Pituitary Tumor Shrinkage
BEVAN, J. S., WEBSTER, J., Burke, C. W., & Scanlon, M. F. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-220 · Cited by 469
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN
Alberti, K. G. M. M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., & Ørskov, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92873-0 · Cited by 457
Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995
Lamberts, S. W. J., Uitterlinden, P., Verschoor, L., van Dongen, K. J., & del Pozo, E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132504 · Cited by 397
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Antunes, P., Ginj, M., Zhang, H., Waser, B., Baum, R. P., Reubi, J. C., & Maecke, H. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0317-x · Cited by 393
Daly, A. F., Tichomirowa, M. A., Petrossians, P., Heliövaara, E., Jaffrain-Rea, M.-L., Barlier, A., Naves, L. A., Ebeling, T., Karhu, A., Raappana, A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2556 · Cited by 384
Self-citationReubi, J. C., Kvols, L. K., Waser, B., Nagorney, D. M., Heitz, P. U., Charboneau, J. W., Reading, C. C., & Moertel, C. G. (1990) · PubMed · Cited by 375
Strowski, M. Z. (2000) · Endocrinology · doi:10.1210/en.141.1.111 · Cited by 359
Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
Freda, P. U., Katznelson, L., van der Lely, A. J., Reyes, C. M., Zhao, S., & Rabinowitz, D. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0260 · Cited by 346
Yttrium-90-labelled somatostatin-analogue for cancer treatment
Otte, A., Mueller-Brand, J., Dellas, S., Nitzsche, E., Herrmann, R., & Maecke, H. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78355-0 · Cited by 335
Buscail, L., Delesque, N., Estève, J. P., Saint-Laurent, N., Prats, H., Clerc, P., Robberecht, P., Bell, G. I., Liebow, C., & Schally, A. V. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2315 · Cited by 327
Valkema, R., Pauwels, S., Kvols, L. K., Barone, R., Jamar, F., Bakker, W. H., Kwekkeboom, D. J., Bouterfa, H., & Krenning, E. P. (2006) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2006.01.001 · Cited by 313
Stimulation and inhibition of adenylyl cyclases mediated by distinct regulatory proteins
Hildebrandt, J. D., Sekura, R. D., Codina, J., Iyengar, R., Manclark, C. R., & Birnbaumer, L. (1983) · Nature · doi:10.1038/302706a0 · Cited by 311
Wild, D., Schmitt, J. S., Ginj, M., Mäcke, H. R., Bernard, B. F., Krenning, E., de Jong, M., Wenger, S., & Reubi, J.-C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1255-5 · Cited by 310
Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase.
Yasuda, K., Rens-Domiano, S., Breder, C. D., Law, S. F., Saper, C. B., Reisine, T., & Bell, G. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88719-7 · Cited by 309
Shimon, I., Taylor, J. E., Dong, J. Z., Bitonte, R. A., Kim, S., Morgan, B., Coy, D. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119225 · Cited by 309
Effects of Somatostatin on the Secretion of Thyrotropin and Prolactin
VALE, W., RIVIER, C., BRAZEAU, P., & GUILLEMIN, R. (1974) · Endocrinology · doi:10.1210/endo-95-4-968 · Cited by 299
Leontiou, C. A., Gueorguiev, M., van der Spuy, J., Quinton, R., Lolli, F., Hassan, S., Chahal, H. S., Igreja, S. C., Jordan, S., Rowe, J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2611 · Cited by 299
Yamada, Y. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2136 · Cited by 294
Molecular cloning and functional expression of a brain-specific somatostatin receptor.
Bruno, J. F., Xu, Y., Song, J., & Berelowitz, M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11151 · Cited by 294
Pasireotide (SOM230): Development, mechanism of action and potential applications
Schmid, H. A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.09.006 · Cited by 290 · cited 1×
“Pasireotide (SOM230; Signifor ) is a multireceptor-targeting somatostatin analog that has a 39-, 30- and 5-fold higher binding affinity for SSTR5, SSTR1 and SSTR3, respectively, and a slightly lower affinity for SSTR2 compared with octreotide (Bruns et al., 2002; Schmid, 2008).”
Boscaro, M., Ludlam, W. H., Atkinson, B., Glusman, J. E., Petersenn, S., Reincke, M., Snyder, P., Tabarin, A., Biller, B. M. K., Findling, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1008 · Cited by 279
Bevan, J. S., Atkin, S. L., Atkinson, A. B., Bouloux, P.-M., Hanna, F., Harris, P. E., James, R. A., McConnell, M., Roberts, G. A., Scanlon, M. F., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-012012 · Cited by 279
Hofland, L. J., van der Hoek, J., Feelders, R., van Aken, M. O., van Koetsveld, P. M., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., de Herder, W. W., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01876 · Cited by 276
O'Carroll, A. M., Lolait, S. J., König, M., & Mahan, L. C. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09269-7 · Cited by 274
Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors
Pivonello, R., Ferone, D., de Herder, W. W., Kros, J. M., Del Basso De Caro, M. L., Arvigo, M., Annunziato, L., Lombardi, G., Colao, A., Hofland, L. J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030837 · Cited by 271
Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)
Vanetti, M., Kouba, M., Wang, X., Vogt, G., & Höllt, V. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81122-3 · Cited by 269
Sharma, K. (1996) · Molecular Endocrinology · doi:10.1210/me.10.12.1688 · Cited by 269
LAMBERTS, S. W. J. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-4-417 · Cited by 265
Fani, M., Del Pozzo, L., Abiraj, K., Mansi, R., Tamma, M. L., Cescato, R., Waser, B., Weber, W. A., Reubi, J. C., & Maecke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.087999 · Cited by 262
Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
Feelders, R. A., de Bruin, C., Pereira, A. M., Romijn, J. A., Netea-Maier, R. T., Hermus, A. R., Zelissen, P. M., van Heerebeek, R., de Jong, F. H., van der Lely, A.-J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1000094 · Cited by 262
Shimon, I., Yan, X., Taylor, J. E., Weiss, M. H., Culler, M. D., & Melmed, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119779 · Cited by 260
Tyrosine Phosphorylation of p85 Relieves Its Inhibitory Activity on Phosphatidylinositol 3-Kinase
Cuevas, B. D., Lu, Y., Mao, M., Zhang, J., LaPushin, R., Siminovitch, K., & Mills, G. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100556200 · Cited by 256
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Kwekkeboom, D. J., & Krenning, E. P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31022 · Cited by 252
Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers
Henry, R. R., Ciaraldi, T. P., Armstrong, D., Burke, P., Ligueros-Saylan, M., & Mudaliar, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1771 · Cited by 251
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
Bevan, J. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1093 · Cited by 249
Newman, C. B., Melmed, S., Snyder, P. J., Young, W. F., Boyajy, L. D., Levy, R., Stewart, W. N., Klibanski, A., Molitch, M. E., & Gagel, R. F. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673422 · Cited by 245
Spengler, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2814 · Cited by 242
All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl Cyclase
Patel, Y. C., Greenwood, M. T., Warszynska, A., Panetta, R., & Srikant, C. B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1088 · Cited by 239
Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.
Schwarz, J. K., Devoto, S. H., Smith, E. J., Chellappan, S. P., Jakoi, L., & Nevins, J. R. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05742.x · Cited by 228
Cozzi, R., Montini, M., Attanasio, R., Albizzi, M., Lasio, G., Lodrini, S., Doneda, P., Cortesi, L., & Pagani, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2347 · Cited by 228
Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours
Aparicio, T., Ducreux, M., Baudin, E., Sabourin, J.-C., De Baere, T., Mitry, E., Schlumberger, M., & Rougier, P. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00073-9 · Cited by 226
Wymenga, A. N. M., Eriksson, B., Salmela, P. I., Jacobsen, M. B., Van Cutsem, E. J. D. G., Fiasse, R. H., Välimäki, M. J., Renstrup, J., de Vries, E. G. E., & Öberg, K. E. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.4.1111 · Cited by 226
Inhibition by Somatostatin on the Release of TSH Induced in Man by Thyrotropin-Releasing Factor
SILER, T. M., YEN, S. S. C., VALE, W., & GUILLEMIN, R. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-38-5-742 · Cited by 224
Theodoropoulou, M., Zhang, J., Laupheimer, S., Paez-Pereda, M., Erneux, C., Florio, T., Pagotto, U., & Stalla, G. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1189 · Cited by 216
Self-citationde Jong, M., Bakker, W. H., Krenning, E. P., Breeman, W. A. P., van der Pluijm, M. E., Bernard, B. F., Visser, T. J., Jermann, E., Béhé, M., Powell, P., et al. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00881807 · Cited by 215
A Critical Analysis of Pituitary Tumor Shrinkage during Primary Medical Therapy in Acromegaly
Melmed, S., Sternberg, R., Cook, D., Klibanski, A., Chanson, P., Bonert, V., Vance, M. L., Rhew, D., Kleinberg, D., & Barkan, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2466 · Cited by 215
SOMATOSTATIN INHIBITS THE RELEASE OF ACETYLCHOLINE INDUCED ELECTRICALLY IN THE MYENTERIC PLEXUS
Guillemin, R. (1976) · Endocrinology · doi:10.1210/endo-99-6-1653 · Cited by 214
Murray, R. D., & Melmed, S. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0027 · Cited by 214
Mercado, M., Borges, F., Bouterfa, H., Chang, T., Chervin, A., Farrall, A. J., Patocs, A., Petersenn, S., Podoba, J., Safari, M., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02825.x · Cited by 214
Chanson, P., Weintraub, B. D., & Harris, A. G. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-3-199308010-00010 · Cited by 212
Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours.
de Herder, W. W., Hofland, L. J., van der Lely, A. J., & Lamberts, S. W. J. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100451 · Cited by 210
de Jong, M., Breeman, W. A., Bakker, W., Kooij, P. P. M., Bernard, B. F., Hofland, L. J., Visser, T. J., Srinivasan, A., Schmidt, M. A., Erion, J. L., et al. (1998) · PubMed · Cited by 209
Schally, A. V., Huang, W. Y., Chang, R. C., Arimura, A., Redding, T. W., Millar, R. P., Hunkapiller, M. W., & Hood, L. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.8.4489 · Cited by 207
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
G Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor Cells
Pan, M. G., Florio, T., & Stork, P. J. S. (1992) · Science · doi:10.1126/science.256.5060.1215 · Cited by 205
Petersenn, S., Schopohl, J., Barkan, A., Mohideen, P., Colao, A., Abs, R., Buchelt, A., Ho, Y.-Y., Hu, K., Farrall, A. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2272 · Cited by 204
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Giustina, A., Mazziotti, G., Torri, V., Spinello, M., Floriani, I., & Melmed, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036411 · Cited by 201
A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells
Jakobs, K. H., Aktories, K., & Schultz, G. (1983) · Nature · doi:10.1038/303177a0 · Cited by 201
Batista, D. L., Zhang, X., Gejman, R., Ansell, P. J., Zhou, Y., Johnson, S. A., Swearingen, B., Hedley-Whyte, E. T., Stratakis, C. A., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1245 · Cited by 201
Role of Somatostatins in Gastroenteropancreatic Neuroendocrine Tumor Development and Therapy
Öberg, K. E., Reubi, J., Kwekkeboom, D. J., & Krenning, E. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.002 · Cited by 200
Kvols, L. K., Oberg, K. E., O'Dorisio, T. M., Mohideen, P., de Herder, W. W., Arnold, R., Hu, K., Zhang, Y., Hughes, G., Anthony, L., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-11-0367 · Cited by 199
Expression cloning of a rat brain somatostatin receptor cDNA.
Kluxen, F. W., Bruns, C., & Lübbert, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4618 · Cited by 198
Teunissen, J. J. M., Kwekkeboom, D. J., & Krenning, E. P. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.016 · Cited by 197
Frank, M. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00146-x · Cited by 191
Plewe, G., Krause, U., Beyer, J., Neufeld, M., & del Pozo, E. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90706-2 · Cited by 191
Cozzi, R., Attanasio, R., Montini, M., Pagani, G., Lasio, G., Lodrini, S., Barausse, M., Albizzi, M., Dallabonzana, D., & Pedroncelli, A. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030110 · Cited by 190
Villard, L., Romer, A., Marincek, N., Brunner, P., Koller, M. T., Schindler, C., Ng, Q. K. T., Mäcke, H. R., Müller-Brand, J., Rochlitz, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.2151 · Cited by 189
Yen, S. S. C., Siler, T. M., & De Vane, G. W. (1974) · New England Journal of Medicine · doi:10.1056/nejm197404252901704 · Cited by 188
Renström, E., Ding, W.-G., Bokvist, K., & Rorsman, P. (1996) · Neuron · doi:10.1016/s0896-6273(00)80183-x · Cited by 186
Cazabat, L., Bouligand, J., Salenave, S., Bernier, M., Gaillard, S., Parker, F., Young, J., Guiochon-Mantel, A., & Chanson, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2291 · Cited by 185
Hofland, L. J., van der Hoek, J., van Koetsveld, P. M., de Herder, W. W., Waaijers, M., Sprij-Mooij, D., Bruns, C., Weckbecker, G., Feelders, R., van der Lely, A.-J., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031344 · Cited by 185
First Clinical Evidence That Imaging with Somatostatin Receptor Antagonists Is Feasible
Wild, D., Fani, M., Behe, M., Brink, I., Rivier, J. E. F., Reubi, J. C., Maecke, H. R., & Weber, W. A. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.088922 · Cited by 183
Khan, S., Krenning, E. P., van Essen, M., Kam, B. L., Teunissen, J. J., & Kwekkeboom, D. J. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.087932 · Cited by 179
Vezzosi, D., Bennet, A., Rochaix, P., Courbon, F., Selves, J., Pradere, B., Buscail, L., Susini, C., & Caron, P. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01901 · Cited by 179
Colao, A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.6.2779 · Cited by 179
Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues
de Jong, M., Breeman, W. A. P., Kwekkeboom, D. J., Valkema, R., & Krenning, E. P. (2009) · Accounts of Chemical Research · doi:10.1021/ar800188e · Cited by 178
H., W., M., S., K., S., G., M., M., H., F., R., J., R., & M., S. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1012-1 · Cited by 177
Tichomirowa, M. A., Barlier, A., Daly, A. F., Jaffrain-Rea, M.-L., Ronchi, C., Yaneva, M., Urban, J. D., Petrossians, P., Elenkova, A., Tabarin, A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0304 · Cited by 175
Self-citationTaboada, G. F., Luque, R. M., Neto, L. V., Machado, E. D. O., Sbaffi, B. C., Domingues, R. C., Marcondes, J. B., Chimelli, L. M. C., Fontes, R., Niemeyer, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0562 · Cited by 174
EPILEPTIC DEATH DUE TO SUFFOCATION DURING SLEEP
Longmore, H. J. A., & Wilson, J. B. (1970) · The Lancet · doi:10.1016/s0140-6736(70)90273-4 · Cited by 174
Differential β-Arrestin Trafficking and Endosomal Sorting of Somatostatin Receptor Subtypes
Tulipano, G., Stumm, R., Pfeiffer, M., Kreienkamp, H.-J., Höllt, V., & Schulz, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313522200 · Cited by 172
Lesche, S., Lehmann, D., Nagel, F., Schmid, H. A., & Schulz, S. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1919 · Cited by 172
Florio, T., Morini, M., Villa, V., Arena, S., Corsaro, A., Thellung, S., Culler, M. D., Pfeffer, U., Noonan, D. M., Schettini, G., et al. (2003) · Endocrinology · doi:10.1210/en.2002-220949 · Cited by 169
Schmid, H. A., & Schoeffter, P. (2004) · Neuroendocrinology · doi:10.1159/000080741 · Cited by 168
Patel, Y. C., Greenwood, M., Kent, G., Panetta, R., & Srikant, C. B. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1412 · Cited by 164
SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells
Kailey, B., van de Bunt, M., Cheley, S., Johnson, P. R., MacDonald, P. E., Gloyn, A. L., Rorsman, P., & Braun, M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00207.2012 · Cited by 164
Weckbecker, G., Briner, U., Lewis, I., & Bruns, C. (2002) · Endocrinology · doi:10.1210/en.2002-220219 · Cited by 163
Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
Murray, R. D., Kim, K., Ren, S.-G., Chelly, M. R., Umehara, Y., & Melmed, S. K. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19933 · Cited by 162
Somatostatin and the immune and haematopoetic system; a review
HAGEN, P. M. V., KRENNING, E. P., KWEKKEBOOM, D. J., REUBI, J. C., ANKER‐LUGTENBURG, V. P. J., LÖWENBERG, B., & LAMBERTS, S. W. J. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb00972.x · Cited by 160
Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook
Eriksson, B., & Öberg, K. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s31 · Cited by 160
Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors
Kwekkeboom, D. J., de Herder, W. W., van Eijck, C. H. J., Kam, B. L. R., van Essen, M., Teunissen, J. J. M., & Krenning, E. P. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.10.004 · Cited by 156
van der Hoek, J., Waaijers, M., van Koetsveld, P. M., Sprij-Mooij, D. M., Feelders, R. A., SCHMID, H. A., Schoeffter, P., Hoyer, D., Cervia, D., Taylor, J. E., et al. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00004.2005 · Cited by 156
Impact of Somatostatin Analogs on the Heart in Acromegaly: A Metaanalysis
Maison, P., Tropeano, A., Macquin‐Mavier, I., Giustina, A., & Chanson, P. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2547 · Cited by 154
Gi alpha 3 and G(o) alpha selectively associate with the cloned somatostatin receptor subtype SSTR2
Law, S. F., Yasuda, K., Bell, G. I., & Reisine, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82045-2 · Cited by 153
Meyerhof, W., Wulfsen, I., Schönrock, C., Fehr, S., & Richter, D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10267 · Cited by 152
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Chahal, H., Trivellin, G., Leontiou, C. A., Alband, N., Fowkes, R. C., Tahir, A., Igreja, S., Chapple, J. P., Jordan, S., Lupp, A., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1111 · Cited by 150
Somatostatin Activation of Mitogen-Activated Protein Kinase via Somatostatin Receptor 1 (SSTR1)
Florio, T., Yao, H. W., Carey, K. D., Dillon, T. J., & Stork, P. A. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.24 · Cited by 150
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
Kaltsas, G., Papadogias, D., Makras, P., & Grossman, A. B. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01116 · Cited by 145
van der Hoek, J., de Herder, W. W., Feelders, R. A., van der Lely, A. J., Uitterlinden, P., Boerlin, V., Bruns, C., Poon, K. W., Lewis, I., Weckbecker, G., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031052 · Cited by 144
Keane, M., Lowrey, G. A., Ettenberg, S. A., Dayton, M. A., & Lipkowitz, S. (1996) · PubMed · Cited by 138
Annamalai, A. K., Webb, A., Kandasamy, N., Elkhawad, M., Moir, S., Khan, F. Z., Maki-Petaja, K. M., Gayton, E. L., Strey, C. H., O’Toole, S. M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3072 · Cited by 138
Inhibition of Adrenocorticotropin Secretion by Somatostatin in Pituitary Cells in Culture*
Richardson, U. I., & Schönbrunn, A. (1981) · Endocrinology · doi:10.1210/endo-108-1-281 · Cited by 133
Liu, D., Martino, G., Thangaraju, M., Sharma, M., Halwani, F., Shen, S., Patel, Y., & Srikant, C. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9244 · Cited by 133
Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis
Strowski, M. Z., Köhler, M. G., Chen, H. Y., Trumbauer, M. E., Li, Z., Szalkowski, D., Gopal-Truter, S., Fisher, J. K., Schaeffer, J. M., Blake, A. D., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2001-0035 · Cited by 130
Zatelli, M. C., Piccin, D., Vignali, C., Tagliati, F., Ambrosio, M. R., Bondanelli, M., Cimino, V., Bianchi, A., SCHMID, H. A., Scanarini, M., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0026 · Cited by 128
Lahlou, H., Saint‐Laurent, N., Estève, J., Eychène, A., Pradayrol, L., Pyronnet, S., & Susini, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304524200 · Cited by 126
Amato, G., Mazziotti, G., Rotondi, M., Iorio, S., Doga, M., Sorvillo, F., Manganella, G., Salle, F. D., Giustina, A., & Carella, C. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01438.x · Cited by 126
Binding properties of somatostatin receptor subtypes
Bruns, C., Raulf, F., Hoyer, D., Schloos, J., Lübbert, H., & Weckbecker, G. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90072-4 · Cited by 125
Heisler, S., Reisine, T., HOOK, V. Y. H., & Axelrod, J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.21.6502 · Cited by 125
The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
Hejna, M., Schmidinger, M., & Raderer, M. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf142 · Cited by 125
From somatostatin to octreotide LAR: evolution of a somatostatin analogue
Anthony, L. B., & Freda, P. U. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903328959 · Cited by 124
Sharma, K., & Srikant, C. B. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980413)76:2<259::aid-ijc14>3.0.co;2-7 · Cited by 124
Singh, V., Brendel, M. D., Zacharias, S., Mergler, S., Jahr, H., Wiedenmann, B., Bretzel, R. G., Plöckinger, U., & Strowski, M. Z. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1578 · Cited by 124
Glucose homeostasis in acromegaly: effects of long‐acting somatostatin analogues treatment
Baldelli, R., Battista, C., Leonetti, F., Ghiggi, M. R., Ribaudo, M. C., Paoloni, A., D’Amico, E., Ferretti, E., Baratta, R., Liuzzi, A., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01876.x · Cited by 124
INHIBITION BY SOMATOSTATIN OF ACTH SECRETION IN NELSON'S SYNDROME
Tyrrell, J. B., Lorenzi, M., Gerich, J. E., & Forsham, P. H. (1975) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-40-6-1125 · Cited by 124
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
de Bruin, C., Pereira, A. M., Feelders, R. A., Romijn, J. A., Roelfsema, F., Sprij-Mooij, D. M., van Aken, M. O., van der Lelij, A., de Herder, W. W., Lamberts, S. W. J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2101 · Cited by 124
Koch, B., Blalock, J., & Schönbrunn, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57381-1 · Cited by 123
Peptide Receptor Targeting in Cancer: The Somatostatin Paradigm
Barbieri, F., Bajetto, A., Pattarozzi, A., Gatti, M., Würth, R., Thellung, S., Corsaro, A., Villa, V., Nizzari, M., & Florio, T. (2013) · International Journal of Peptides · doi:10.1155/2013/926295 · Cited by 121
Gromada, J., Høy, M., Buschard, K., Salehi, A., & Rorsman, P. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00519.x · Cited by 120
Benali, N. L., Cordelier, P., Calise, D., Pagès, P., Rochaix, P., Nagy, A., Estève, J., Pour, P. M., Schally, A. V., Vaysse, N., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130196697 · Cited by 120
[The pituitary and hormonal calcium regulation system].
Salzer, G. M. (1971) · PubMed · Cited by 120
Characterization of cloned human somatostatin receptor SSTR5.
O'Carroll, A.-M., Raynor, K., Lolait, S. J., & Reisine, T. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09683-x · Cited by 117
Drouin, J., Léan, A. D., RAINVILLE, D., Lachance, R., & Labrie, F. (1976) · Endocrinology · doi:10.1210/endo-98-2-514 · Cited by 117
Viollet, C., Vaillend, C., Videau, C., Bluet‐Pajot, M., Ungerer, A., L’Héritier, A., Kopp, C., Potier, B., Billard, J., Schaeffer, J. M., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00249.x · Cited by 116
Antiproliferative Effect of Somatostatin and Analogs
Bousquet, C., Puente, E., Buscail, L., Vaysse, N., & Susini, C. (2001) · Chemotherapy · doi:10.1159/000049159 · Cited by 116
Faiss, S., Räth, U., Mansmann, U., Caird, D. M., Clemens, N., Riecken, E. O., & Wiedenmann, B. (1999) · Digestion · doi:10.1159/000007693 · Cited by 116
Körner, M., Waser, B., Schönbrunn, A., Perren, A. A., & Reubi, J. C. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31823d07f3 · Cited by 116
Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis
Albini, A., Florio, T., Giunciuglio, D., Masiello, L., Carlone, S., Corsaro, A., Thellung, S., Cai, T., Noonan, D. M., & Schettini, G. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.6.647 · Cited by 115
Bousquet, C., Delesque, N., Lopez, F., Saint‐Laurent, N., Estève, J., Bedecs, K., Buscail, L., Vaysse, N., & Susini, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.7099 · Cited by 115
Cerovac, V., Garcia, J. L. M., Rubinfeld, H., Buchfelder, M., Losa, M., Florio, T., Páez-Pereda, M., Stalla, G. K., & Theodoropoulou, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2951 · Cited by 115
Self-citationCazabat, L., Libé, R., Perlemoine, K., René-Corail, F., Burnichon, N., Gimenez‐Roqueplo, A., Pasquier-Fediaevsky, L. D., BERTAGNA, X. Y., Clauser, É., Chanson, P., et al. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0181 · Cited by 114
Florio, T., Barbieri, F., Spaziante, R., Zona, G., Hofland, L. J., van Koetsveld, P. M., Feelders, R., Stalla, G. K., Theodoropoulou, M., Culler, M. D., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0271 · Cited by 110
Self-citationRegulation of Acidification and Apoptosis by SHP-1 and Bcl-2
Thangaraju, M., Sharma, K., Leber, B. F., Andrews, D. W., Shen, S., & Srikant, C. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29549 · Cited by 109
Ferrante, E., Pellegrini, C., Bondioni, S., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01191 · Cited by 109
Lamberts, S. W. J., Uitterlinden, P., & Klijn, J. M. G. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200760 · Cited by 109
Cescato, R., Waser, B., Fani, M., & Reubi, J. C. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.095778 · Cited by 108
Schottelius, M., Poethko, T., Herz, M., Reubi, J., Kessler, H., Schwaiger, M., & Wester, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0359 · Cited by 108
Somatostatin receptors in human prostate and prostate cancer.
Reubi, J. C., Waser, B., Schaer, J., et al. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.9.7673428 · Cited by 106
Bosch, J., Adriaensen, D., Nassauw, L. V., et al. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.04.003 · Cited by 106
Tallent, M. K., Liapakis, G., O’Carroll, A., Lolait, S. J., Dichter, M. A., & Reisine, T. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00510-2 · Cited by 104
Patel, Y., & Wheatley, T. A. (1983) · Endocrinology · doi:10.1210/endo-112-1-220 · Cited by 104
Bito, H., Mori, M., Sakanaka, C., Takano, T., Honda, Z.-I., Gotoh, Y., Nishida, E., & Shimizu, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99936-9 · Cited by 103
Teijeiro, R., Rios, R., Costoya, J. A., Castro, R., Belló, J., Devesa, J., & Arce, V. M. (2002) · Cellular Physiology and Biochemistry · doi:10.1159/000047824 · Cited by 99
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review
Mazziotti, G., & Giustina, A. (2009) · Pituitary · doi:10.1007/s11102-009-0169-z · Cited by 98
Octreotide exerts different effects in vivo and in vitro in Cushing's disease
Stalla, G. K., Brockmeier, S. J., Renner, U., Newton, C., Buchfelder, M., Stalla, J., & Müller, O. A. (1994) · European Journal of Endocrinology · doi:10.1530/eje.0.1300125 · Cited by 96
Self-citationFerjoux, G., Lopez, F., Estève, J., Ferrand, A., Vivier, É., Vely, F., Saint‐Laurent, N., Pradayrol, L., Buscail, L., & Susini, C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0069 · Cited by 95
Bousquet, C., Guillermet‐Guibert, J., Saint‐Laurent, N., Archer-Lahlou, É., Lopez, F., Fanjul, M., Ferrand, A., Fourmy, D., Pichereaux, C., Monsarrat, B., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601279 · Cited by 95
The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells
Florio, T., Rim, C., Hershberger, R. E., Loda, M. F., & Stork, P. A. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1289 · Cited by 94
Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs
Kreienkamp, H., Akgün, E., Baumeister, H., Meyerhof, W., & Richter, D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01582-3 · Cited by 94
Zatelli, M. C., Piccin, D., Tagliati, F., Ambrosio, M. R., Margutti, A., Padovani, R., Scanarini, M., Culler, M. D., & Uberti, E. C. D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021825 · Cited by 94
Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
Colao, A., Pivonello, R., Galderisi, M., Cappabianca, P., Auriemma, R. S., Galdiero, M., Cavallo, L. M., Esposito, F., & Lombardi, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0299 · Cited by 93
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
Zatelli, M. C., Minoia, M., Filieri, C., Tagliati, F., Buratto, M., Ambrosio, M. R., Lapparelli, M., Scanarini, M., & Uberti, E. C. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1641 · Cited by 92
Hodge, D., Marsh, W. J., Parker, H. E., Ogunnowo-Bada, E., Riches, C. H., Habib, A. M., Evans, M. L., Gribble, F. M., & Reimann, F. (2012) · Diabetologia · doi:10.1007/s00125-012-2663-5 · Cited by 91
Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
Fusco, A., Gunz, G., Jaquet, P., Dufour, H., Germanetti, A. L., Culler, M. D., Barlier, A., & Saveanu, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0806 · Cited by 88
Cited by
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
A Consensus Statement on acromegaly therapeutic outcomes
Melmed, S., Bronstein, M. D., Chanson, P., Klibanski, A., Casanueva, F. F., Wass, J. A. H., Strasburger, C. J., Luger, A., Clemmons, D. R., & Giustina, A. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0058-5 · Cited by 561
Near-infrared (NIR) fluorescence-emitting small organic molecules for cancer imaging and therapy
Li, H., Kim, Y., Jung, H., Hyun, J. Y., & Shin, I. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00722c · Cited by 356
Nanoscale Self-Assembly for Therapeutic Delivery
Yadav, S., Sharma, A. K., & Kumar, P. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00127 · Cited by 324
Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015388 · Cited by 253
Metadata
- Authors
- Theodoropoulou, M., & Stalla, G. K.
- Venue
- Frontiers in Neuroendocrinology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 34
- Issue
- 3
- Pages
- 228-252
- ISSN
- 0091-3022 (ISSN-L)
- OpenAlex
- W2015321769
- Cited by
- 410
- References
- 289
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.